Renal AA amyloidosis following COVID-19 infection
Primarily a respiratory illness, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has a range of extra-pulmonary involvement, including the kidneys, which are often affected. This infection has been associated with the overproduction of serum amyloid A protein, resulting in systemic AA amyloidosis. We report a case of renal AA amyloidosis presenting as a nephrotic syndrome in a patient without any underlying risk factor except COVID-19 infection. This article offers preliminary insights into a potential connection between this emerging viral disease and this complication, awaiting confirmation through future research.
Authors
- Said Aissa Khelifa (ORCID: https://orcid.org/0000-0001-9541-8175)
- T. Ben Achour
- I. Naceur (ORCID: https://orcid.org/0000-0003-2805-7538)
- Maysam Jridi (ORCID: https://orcid.org/0000-0002-3036-8901)
- Monia Smiti
- Fatma Said
Institutions
- Hôpital La Rabta (TN)
Publication Details
- Journal
- Néphrologie & Thérapeutique
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1684/ndt.2025.151
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00